Insider Transactions in Q1 2024 at Inovio Pharmaceuticals, Inc. (INO)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2024
|
Peter Kies CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,466
-7.37%
|
$27,728
$8.16 P/Share
|
|
Feb 26
2024
|
Peter Kies CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,875
+11.0%
|
-
|
|
Feb 26
2024
|
Laurent Humeau Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,351
-5.41%
|
$18,808
$8.16 P/Share
|
|
Feb 26
2024
|
Laurent Humeau Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,734
+11.56%
|
-
|
|
Feb 26
2024
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,728
-8.48%
|
$29,824
$8.16 P/Share
|
|
Feb 26
2024
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,731
+14.65%
|
-
|
|
Feb 26
2024
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,916
+1.21%
|
-
|